| Financial Year |
March 31 2023 |
| Monetary Funds |
216,228,938.07 |
| Held-for-trading Financial Assets |
56,477,998.13 |
| Notes Receivable |
91,492,522.80 |
| Accounts Receivable |
855,895,649.65 |
| Advances to Suppliers |
55,791,854.52 |
| Other Receivables |
21,646,646.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
484,894,073.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
182,244,503.73 |
| Total Current Assets |
2,293,319,815.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,871,250.00 |
| Long-term Equity Investment |
20,629,425.09 |
| Investment Properties |
-- |
| Fixed Assetes |
170,154,374.45 |
| Under-construction Projects |
117,017,327.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,309,515.61 |
| R&D expenses |
47,616,752.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
43,166,784.16 |
| Deferred Income Tax Assets |
99,701,141.12 |
| Other Non-Current Assets |
45,039,567.46 |
| Sub-Total of Non-Current Assets |
760,041,515.34 |
| Total Assets |
3,053,361,330.95 |
| Short-Term Loans |
379,482,148.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
493,274,433.10 |
| Accounts Payable |
531,268,286.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,040,607.45 |
| Taxes Payable |
19,257,282.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,106,343.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,263,191.16 |
| Other Current Liabilities |
7,539,026.85 |
| Sub-Total of Current Liabilities |
1,634,774,187.74 |
| Long-term Loans |
2,902,358.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
61,800,199.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
27,566,003.96 |
| Deferred Income Tax Liabilities |
1,327,511.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
160,902,027.50 |
| Total Liabilities |
1,795,676,215.24 |
| Paid-In Capital(Or Share Stock) |
126,967,368.00 |
| Capital Surplus |
995,507,922.07 |
| Surplus Reserve |
41,424,083.04 |
| LESS:Treasury Stock |
194,600.00 |
| Undistributed Profits |
82,205,387.04 |
| Minority Stockholder's Interest |
4,595,273.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,253,089,842.01 |
| Owner's Equity（Stockholder's Equity） |
1,257,685,115.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,053,361,330.95 |
